Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:15 PM
Ignite Modification Date:
2025-12-24 @ 9:15 PM
NCT ID:
NCT00150904
Eligibility Criteria:
Inclusion Criteria:
All patients where the treating physicians decides to start treatment with peginterferon and ribavirin for treatment of hepatitis C
* HCV mono-infection or HCV / HIV coinfection
* Genotype 1
* Compliant for outpatient visits
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00150904
Study Brief:
Protocol Section:
NCT00150904